Bringing IO Together: How an Immunologist and Oncologist Collaborate in an Emerging Field

Media Coverage
illustration of the cancer-immunity cycle

Drug Discovery World

For many years, immunology and oncology operated as separate disciplines within drug discovery. However, recent advances in immuno-oncology (IO) have demonstrated what can be achieved when the two disciplines join forces in developing novel treatments for patients. From checkpoint inhibitors to CAR-T cells and model selection designed to reflect more personalised medicine approaches, immuno-oncology is shifting how both immunologists and oncologists approach drug discovery and development.

Read the Full Article